Current impact of gene technology on healthcare

This publication has 74 references indexed in Scilit:

• The therapeutic antibodies market to 2008
  European Journal of Pharmaceutics and Biopharmaceutics, 2005
• Role of Pharmacoeconomic Analysis in R&D Decision Making
  PharmacoEconomics, 2005
• Evolving Treatment Strategies for Anaemia in Cancer: Experience with Epoetin Beta
  Oncology, 2004
• CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA
  International Journal of Technology Assessment in Health Care, 2003
• Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds
  Gastrointestinal Endoscopy, 2003
• STATUS AND POTENTIAL OF GENE THERAPY IN CLINICAL MEDICINE
  International Journal of Technology Assessment in Health Care, 2002
• The Cost‐Effectiveness of Interleukin‐1 Genetic Testing for Periodontal Disease
  The Journal of Periodontology, 2002
• Assessing the cost-effectiveness of pharmacogenomics
  AAPS PharmSci, 2000
• A Comparison of the Costs and Benefits of Recombinant Human Erythropoietin (Epoetin) in the Treatment of Chronic Renal Failure in 5 European Countries
  PharmacoEconomics, 1992
• Genes.Benjamin Lewin
  The Quarterly Review of Biology, 1984